Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds
The three-year study of tirzepatide found adults with prediabetes and obesity or overweight taking the drug weekly saw the risk of progression to diabetes lower by 94 per cent.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
